FCM
IGMS

Flinton Capital Management’s IGM Biosciences IGMS Stock Holding History

Flinton Capital Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$167K Buy
+9,392
New +$190K 0.01% 695

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Flinton Capital Management's IGMS Position: Q3 2019 in Review

Flinton Capital Management opened a new position in IGM Biosciences (IGMS) in Q3 2019: 9,392 shares worth $167K. The stake represents 0.01% of the portfolio and ranks #695 among its holdings.

33 funds tracked by Wall St. Rank hold IGMS as of Q3 2019.

  • Flinton Capital Management held 9,392 shares of IGM Biosciences worth $167K as of Q3 2019.
  • IGM Biosciences was a new Flinton Capital Management position in Q3 2019.
  • IGM Biosciences made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #695 holding.
  • 33 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.